Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: v

Summaries of Product Characteristics 1 - 30 of 210
1  2  3  4  5  6  7  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	V-Pen 50 mg-ml rakeet oraaliliuosta varten SPC 2023-12-20
PL	Resepti	V-Pen mega, V-Pen 1500 tabletti, kalvopäällysteinen SPC 2023-11-01
		European Medicines Agency's website: Vaborem (ent. Vabomere) - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Vabysmo - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Vafseo - EMA: EPAR PI Finnish Swedish
PL	Resepti	Vagidonna 10 mikrog emätinpuikko, tabletti SPC 2022-02-21
PL	Resepti	Vagifem 10 mikrog emätinpuikko, tabletti SPC 2022-08-04
PL	Resepti	Vagiprev ,120 mg-0,015 mg per 24 tuntia, depotlääkevalmiste, emättimeen SPC 2022-10-28
PL	Resepti	Vagirux 0,01 mg emätinpuikko,tabletti SPC 2022-04-15
PL	Resepti/itsehoito	Valaciclovir ratiopharm 500 mg tabletti, kalvopäällysteinen SPC 2022-11-22
PL	Resepti	Valarox 10 mg_80 mg, 20 mg_80 mg, 10 mg_160 mg, 20 mg_160 mg tabletti, kalvopäällysteinen SPC 2017-01-27
PL	Resepti/itsehoito	Valavir 500 mg tabletti, kalvopäällysteinen SPC 2022-11-18
PL	Resepti	Valcyte 50 mg-ml jauhe oraaliliuosta varten SPC 2021-12-17
		European Medicines Agency's website: Valdoxan - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Valeriamed yö-natt tabletti, päällystetty SPC 2016-09-19
PL	Resepti	Valganciclovir Accord 450 mg tabletti, kalvopäällysteinen SPC 2022-01-19
PL	Resepti	Valganciclovir Orion 450 mg tabletti, kalvopäällysteinen SPC 2022-01-28
PL	Resepti	Valganciclovir Sandoz 450 mg tabletti, kalvopäällysteinen SPC 2020-11-26
PL	Resepti/itsehoito	Valorin 500 mg tabletti, kalvopäällysteinen SPC 2023-01-11
PL	Resepti	Valproat Life Medical 100 mg-ml injektio-infuusioneste, liuos SPC 2022-10-28
PL	Resepti	Valproat Sandoz 300 mg, 500 mg depottabletti SPC 2023-12-08
PL	Resepti	Valsarstad 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2020-10-21
PL	Resepti	Valsartan Actavis 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2023-05-11
PL	Resepti	Valsartan Actavis 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2023-05-11
PL	Resepti	Valsartan Krka 320 mg tabletti, kalvopäällysteinen SPC 2022-09-30
PL	Resepti	Valsartan Krka 40 mg, 80 mg, 160 mg tabletti, kalvopäällysteinen SPC 2022-01-31
PL	Resepti	Valsartan Sandoz 80 mg, 160 mg tabletti, kalvopäällysteinen SPC 2021-05-20
PL	Resepti	Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-11-28
PL	Resepti	Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-11-28
PL	Resepti	Valsartan-Hydrochlorothiazide Sandoz 80 mg-12.5 mg, 160 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2022-03-31
1  2  3  4  5  6  7  |  Next 30   >